Preliminary Standardization of Shrungyaadi Shaarkar – A Potential Drug for Tamaka Shwasa
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.1, No. 6)Publication Date: 2018-11-10
Authors : Meenakshi Verma Priyanka Gupta;
Page : 25-26
Keywords : Shringyadi Shrungyaadi; Tamaka Shwasa; Bronchial Asthma; Ayurveda.;
Abstract
Tamaka Shwasa is a troublesome, stressful disease of today's era and is well known for its episodic and chronic course which afflicts the human race Though incidence of Tamaka Shwasa is increasing in day to day practice and at alarming rate but very few patients need intensive care and most of the patients can be managed effectively by Ayurvedic line of treatment. The drug Shrugyadi Shaarkar consists Karkatashrungi, Sunthi, Pippali, Maricha, Kachura, Nagarmotha, Puskarmula, Sharkara ingredients which excellently balancing each other in Rasa-Panchaka and enhancing the Vatakaphahara, Deepana, Pachana and Vatanulomana properties. The main factor in this disease as in many other diseases is Ama and the Deepana-Pachana properties of the drug will digest the Ama and Sothaharatwa Karma.So this compound was analyzed and standardized scientifically through qualitative and quantitative analysis by physico-chemical parameters, This will help for the use of this formulation in Tamak Shwasa.
Other Latest Articles
- Development and Validation of a New HPLC Method for the Simultaneous Estimation of Saxagliptine and Dapagliflozin and Its Application in Pharmacokinetic Studies
- Marchiafava Bignami Disease – Typical and Atypical Etiologies
- Effect of Resistance Exercise on Hypertension
- Assessment of Knowledge of Lassa fever Infection among the Undergraduate Students of University of Nigeria, Nsukka, Enugu State, Nigeria
- Evaluation of Anti-Inflammatory Activity of Methanolic Extract of Fruits of Solanum Xanthocarpum Schrad & Wendl in Albino Rats
Last modified: 2018-11-10 21:50:16